Newsroom

NEW YORK--(BUSINESS WIRE)--Magic Molecule, a hypochlorous acid-based skincare brand, today announced that its FDA-cleared bestselling Skin Spray is now available nationally at all 500+ Whole Foods Market stores. This milestone marks the first time that Whole Foods has approved a hypochlorous acid skin care product in its stores, reflecting the retailer’s evolving clean-ingredient standards and growing consumer demand for gentle, science-backed skin solutions. “As the first hypochlorous acid bra...

NEW YORK--(BUSINESS WIRE)--Definium Therapeutics, Inc. (formerly Mind Medicine (MindMed) Inc.), (NASDAQ: DFTX), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced that members of the Company’s management team will participate in the following investor conferences: TD Cowen 46th Annual Health Care Conference Presentation Date and Time: Monday, March 2, 2026 at...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust RBA American Industrial Renaissance UCITS ETF 23.02.2026 AIRR LN IE000U6ABUJ7 2,350,002.00 USD 68,068,049.10 28.965  ...

CHATSWORTH, Calif. & BRAY, Ireland--(BUSINESS WIRE)--Canoga Perkins and Druid Software showcased their partnership with demonstrating FRER and TSN Demo at the Winter 2025 Druid Demo Days....

BIRMINGHAM, Ala.--(BUSINESS WIRE)--Protective Life Corporation, a U.S. subsidiary of Dai-ichi Life Holdings, Inc. (TSE:8750), today announced retired professional tennis standout John Isner as its new brand ambassador, aligning the company’s long-term approach to financial protection with one of the most consistent careers in modern tennis. Known for his record-breaking serve and nearly two decades competing on the Association of Tennis Professionals (ATP) Tour, Isner built a career defined by...

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the fourth quarter and fiscal year ended December 31, 2025. Fourth Quarter Business Highlights Set patient census records for Sleep Health, Respiratory Health, and Wellness at Home, and a patient retention...

BOSTON--(BUSINESS WIRE)--American Tower Corporation (NYSE: AMT) today reported financial results for the quarter and full year ended December 31, 2025. Steven Vondran, American Tower’s Chief Executive Officer, stated, “We delivered another strong year, achieving high-single-digit growth in AFFO per Share, as adjusted, while continuing to execute our strategy. Leasing demand across our global tower portfolio and data center business remains robust, underpinned by sustained growth in mobile data...

NEW YORK--(BUSINESS WIRE)--Bowhead Specialty Holdings Inc. (NYSE: BOW), a specialty lines insurance group focused on providing casualty, professional liability and healthcare liability insurance products, delivered through complementary “craft” and “digital” underwriting models, today announced financial results for the fourth quarter and year ended December 31, 2025(1). Fourth Quarter 2025 Highlights Gross written premiums increased 21.3% to $224.1 million. Net income of $14.8 million, or $0.4...

WILMINGTON, Del.--(BUSINESS WIRE)--PCA Global Ventures, a global leader in compassionate customer care and specialized debt recovery collection solutions, today announced a new partnership with Wilmington University to deliver a comprehensive, company-wide artificial intelligence training program. The initiative represents PCA Global Ventures’ first education collaboration with a local university and underscores the company’s continued investment in workforce development, innovation, and commun...

NEW YORK--(BUSINESS WIRE)--BNB Plus Corp. (Nasdaq: BNBX) ("BNBX" or the "Company") today announced that its biopharmaceutical subsidiary, LineaRx, Inc. ("LineaRx"), has received two new orders for LineaDNA from well-established developers of genetic medicines. Production and shipment of both orders is expected to be completed prior to June 2026. "We're pleased to receive these new orders from leading genetic medicine companies,” said Clay Shorrock, President and CEO of BNBX. “We believe our con...